Quick Overview
- Oracle shares have tumbled approximately 29% year-to-date through early April 2026, even as the company posts impressive revenue figures.
- Fiscal third-quarter revenue reached $17.2 billion, marking a 22% year-over-year increase and surpassing analyst forecasts.
- The company’s remaining performance obligations (RPO) backlog jumped to $553 billion from $455 billion just six months prior.
- Oracle has outlined plans for $50 billion in capital spending during fiscal 2026, with another $50 billion to be raised through debt and equity financing.
- Wall Street remains divided, with analyst price targets spanning from $160 to $400, highlighting sharp disagreement about profitability timelines.
Oracle’s performance this year presents a confusing picture for investors. While the company continues delivering robust growth metrics and building a massive contract pipeline, the stock has dropped almost 30% since the start of the year. The disconnect has sparked heated debate across the analyst community.
During its fiscal third quarter of 2026, Oracle posted revenue of $17.2 billion, representing 21.7% growth compared to the same period last year and exceeding Wall Street’s $16.91 billion estimate. The company delivered $1.79 in earnings per share, topping the $1.71 consensus forecast. Management also raised its fiscal 2027 revenue projection to $90 billion.
The backlog numbers paint an even more compelling picture. By March 2026, remaining performance obligations had swelled to $553 billion, a significant jump from the $455 billion reported in September 2025. This represents a substantial pipeline of future contracted revenue.
So what’s causing the stock decline?
The Price of Rapid Expansion
Oracle has projected fiscal 2026 capital expenditures will hit $50 billion — representing more than double what the company spent the previous year. Management has also outlined plans to secure another $50 billion through a combination of debt issuance and equity raises to finance cloud infrastructure buildout. As of December 2025, the company’s debt burden stood at approximately $100 billion.
This represents significant financial leverage. Market participants are scrutinizing cash flow generation carefully, understanding that returns on these massive infrastructure investments won’t materialize immediately.
Melius analyst Ben Reitzes downgraded the stock to Hold in February, setting a $160 price target. His rationale centered on the argument that Oracle deserves infrastructure company-level valuation multiples rather than traditional software premiums — particularly given that meaningful free cash flow generation may not arrive until the 2030s.
Compounding investor concerns, Oracle announced approximately 30,000 job cuts delivered through mass email communication, a decision that may reduce expenses in the near term but has raised questions regarding operational execution and employee sentiment.
The Bull and Bear Debate
Not all analysts share this pessimistic outlook. JPMorgan upgraded Oracle to Overweight in March, assigning a $210 price target. The firm characterized the selloff as “drastic” and suggested the risk-reward profile had improved significantly more than the underlying business fundamentals had deteriorated.
Mizuho analyst Siti Panigrahi maintained her Buy rating while adjusting her price target downward from $400 to $320. She emphasized Oracle’s cloud infrastructure advantages as difficult for competitors to replicate. Panigrahi also highlighted an important shift in enterprise AI adoption patterns — companies increasingly prefer bringing AI capabilities to their existing data repositories rather than migrating data to new platforms, a trend that favors Oracle’s positioning.
KeyBanc’s Jackson Ader kept an Overweight rating with a $300 target, characterizing Oracle as a comprehensive AI investment spanning infrastructure, applications, and data layers. The company’s recently launched Fusion Agentic Applications — designed for finance, human resources, supply chain management, and customer experience functions — represent a key component of this investment thesis.
Regarding insider activity, EVP Douglas Kehring divested 35,000 shares in January at approximately $194.89 per share, reducing his stake by roughly 51%. CEO Clayton Magouyrk sold 10,000 shares in February at $155.23. Corporate insiders collectively control 40.9% of outstanding shares.
As of early April, ORCL opened trading at $138.00, significantly below its 52-week peak of $345.72 and nearing its 52-week low of $121.24. The consensus analyst price target stands at $260.71, suggesting considerable upside potential — assuming the optimistic timeline projections prove accurate.





